| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
34,850,000 |
| Market
Cap: |
9.17(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1389 - $0.368 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Applied Molecular Transport is a clinical-stage biopharmaceutical company utilizing its proprietary technology platform to design and develop a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Co. has two oral biologics in clinical development. Co.'s product candidate, AMT-101, is in Phase 2 development for patients with ulcerative colitis and related inflammatory indications. Co.'s second product candidate, AMT-126 is in Phase 1 development for diseases related to intestinal epithelium barrier function defects.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
278,643 |
| Total Buy Value |
$0 |
$0 |
$0 |
$610,243 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
6 |
| Total Shares Sold |
0 |
599,209 |
1,097,868 |
1,140,781 |
| Total Sell Value |
$0 |
$97,534 |
$178,625 |
$257,300 |
| Total People Sold |
0 |
3 |
3 |
6 |
| Total Sell Transactions |
0 |
5 |
14 |
43 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lamond David |
Director |
– • – |
2022-05-23 |
4 |
B |
$3.26 |
$109,210 |
I/I |
33,500 |
1,077,519 |
2.1 |
-70% |
|
| Lamond David |
Director |
– • – |
2022-05-20 |
4 |
B |
$3.08 |
$101,640 |
I/I |
33,000 |
1,044,019 |
2.1 |
-69% |
|
| Cross Shawn |
President & COO |
• – – |
2022-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
69,750 |
|
- |
|
| Hants Brandon |
CFO |
• – – |
2022-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
35,300 |
|
- |
|
| Boeding Chad |
CEO of Managing Member |
– – – |
2022-05-13 |
4 |
B |
$4.17 |
$124,124 |
I/I |
29,763 |
8,337,518 |
0.01 |
-73% |
|
| Boeding Chad |
CEO of Managing Member |
– – – |
2022-05-12 |
4 |
B |
$3.88 |
$125,634 |
I/I |
32,380 |
8,307,755 |
0.01 |
-71% |
|
| Vandevender Aaron |
Director |
– • – |
2022-03-01 |
4 |
B |
$6.34 |
$290,930 |
D/D |
45,888 |
62,659 |
2.39 |
-61% |
|
| Vandevender Aaron |
Director |
– • – |
2022-02-28 |
4 |
B |
$6.51 |
$26,769 |
D/D |
4,112 |
16,771 |
2.39 |
-64% |
|
| Hants Brandon |
VP, Finance & Bus. Ops. |
• – – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,300 |
27,800 |
|
- |
|
| Mrsny Randall Ph.d. |
Chief Scientific Officer |
• • – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
17,250 |
20,750 |
|
- |
|
| Bhatt Elizabeth |
Chief Bus. & Strategy Officer |
• – – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
17,250 |
48,750 |
|
- |
|
| Rich Douglas A. |
Chief Technical Officer |
• – – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
19,200 |
59,200 |
|
- |
|
| Kanwar Bittoo |
Chief Medical Officer |
• – – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
21,600 |
84,600 |
|
- |
|
| Mahmood Tahir Ph.d. |
Chief Executive Officer |
• • – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
78,000 |
|
- |
|
| Cross Shawn |
Chief Financial Officer |
• – – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
20,250 |
51,750 |
|
- |
|
| Mahmood Tahir Ph.d. |
Chief Executive Officer |
• • – |
2022-01-28 |
4 |
B |
$7.88 |
$23,640 |
D/D |
3,000 |
3,000 |
2.81 |
-54% |
|
| Cross Shawn |
Chief Financial Officer |
• – – |
2021-12-24 |
4 |
A |
$0.00 |
$0 |
D/D |
31,500 |
31,500 |
|
- |
|
| Kanwar Bittoo |
Chief Medical Officer |
• – – |
2021-12-24 |
4 |
A |
$0.00 |
$0 |
D/D |
31,500 |
63,000 |
|
- |
|
| Rich Douglas A. |
Chief Technical Officer |
• – – |
2021-12-24 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
|
- |
|
| Bhatt Elizabeth |
Chief Bus. & Strategy Officer |
• – – |
2021-12-24 |
4 |
A |
$0.00 |
$0 |
D/D |
31,500 |
31,500 |
|
- |
|
| Hants Brandon |
VP, Finance & Bus. Ops. |
• – – |
2021-12-24 |
4 |
A |
$0.00 |
$0 |
D/D |
15,500 |
15,500 |
|
- |
|
| Kanwar Bittoo |
Chief Medical Officer |
• – – |
2021-12-22 |
4 |
OE |
$2.38 |
$74,970 |
D/D |
31,500 |
31,500 |
|
- |
|
| Mrsny Randall Ph.d. |
Chief Scientific Officer |
• • – |
2021-12-09 |
4 |
B |
$14.99 |
$52,464 |
D/D |
3,500 |
3,500 |
2.81 |
-69% |
|
| Epq Llc, Amtc Ps |
Owner |
– – – |
2021-11-17 |
4 |
B |
$22.38 |
$159,684 |
I/I |
7,135 |
8,275,375 |
0.01 |
-67% |
|
| Epq Llc, Amtc Ps |
Owner |
– – – |
2021-11-16 |
4 |
B |
$22.57 |
$90,298 |
I/I |
4,000 |
8,268,240 |
0.01 |
-67% |
|
52 Records found
|
|
Page 1 of 3 |
|
|
